Eva Riveira Muñoz
Eva Riveira Muñoz (b. 1977) obtained a degree in Biology from the University of Santiago de Compostela (USC). She then moved to Brussels (Belgium) to pursue a PhD degree, which she obtained from the Université Catholique de Louvain in 2007. Returning to Spain, she spent three years as a post-doc at the Centre for Genomic Regulation in Barcelona. In 2012 she moved to IrsiCaixa, where she is now working as a post-doc at the Virus-Host Interactions group, led by Ester Ballana.
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.
Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA.
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.